New pill aims to help seniors regain strength and mobility

NCT ID NCT07390552

Recruiting now Disease control Sponsor: Pluto Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental oral medication, PLH-2301, in 168 adults aged 65 and older who have sarcopenia (age-related muscle loss). Participants take either a placebo or one of three doses daily for 12 weeks. The main goal is to see if the drug improves physical function, such as walking speed and balance, compared to placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA IN ELDERLY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOPENIA IN ELDERLY

Contacts and locations

Locations

Korea University Anam Hospital
RECRUITING

Seoul, Seoul, 02841, South Korea
Korea University Guro Hospital
RECRUITING

Seoul, Seoul, 08308, South Korea
Seoul National University Bundang Hospital
RECRUITING

Seongnam-si, Gyeonggi-do, South Korea
Seoul St. Mary's Hospital
RECRUITING

Seoul, Seoul, 06591, South Korea
The Catholic University of Korea, St. Vincent's Hospital
RECRUITING

Suwon, Gyeonggi-do, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.